Cellgene

Celgene drug shown to be effective, safe in psoriasis trial
Reuters
Sun, 03/3/13 - 11:22 am
Cellgene
psoriasis
apremilast
This Week in Biotech: Part 1
Motley Fool
Sun, 01/27/13 - 11:07 am
Cellgene
Eli Lilly
Biogen Idec
Vanda
Celsion
Will Celgene’s Top Institutional Shareholders BUY More After the Stock Buyback?
Wall Street Cheat Street
Sat, 06/16/12 - 12:44 pm
Cellgene
Results from a Randomized Study of REVLIMID® (Lenalidomide) and Rituximab (R2) in Patients with Recurrent Follicular Lymphoma Presented at ASCO
Yahoo/Business Wire
Sun, 06/3/12 - 11:10 am
Revlimid
rituximab
follicular lymphoma
Cellgene
Biotech: A “Stock Picker’s Delight,” Says Morgan Stanley
Barron's
Sat, 02/11/12 - 11:36 am
Biogen Idec
Cellgene
Gilead Sciences
Celgene International Sarl Releases Results of Phase II Study on Multiple Myeloma Patients
Trading Markets
Sat, 06/12/10 - 10:14 am
Cellgene
Multiple Myeloma
dexamethasone
pomalidomide
lenalidomide
Data from Combination of REVLIMID® and Rituxan® in Untreated Indolent B-Cell Non-Hodgkin's Lymphoma Presented at ASCO
Yahoo/BusinessWire
Sat, 06/5/10 - 09:59 am
non-Hodgkin's lymphoma
Revlimid
Rituxan
Cellgene
ASCO's Big Winner
Motley Fool
Tue, 06/2/09 - 05:44 pm
ASCO
Cougar Biotechnology
Big Pharma
Pfizer
Celldex
Genentech
Cellgene